nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—CYP3A4—Temozolomide—malignant glioma	0.215	1	CbGbCtD
Oxcarbazepine—Hemianopia—Temozolomide—malignant glioma	0.0357	0.057	CcSEcCtD
Oxcarbazepine—Status epilepticus—Temozolomide—malignant glioma	0.0175	0.0279	CcSEcCtD
Oxcarbazepine—Leg edema—Temozolomide—malignant glioma	0.0153	0.0244	CcSEcCtD
Oxcarbazepine—Hemiplegia—Carmustine—malignant glioma	0.0119	0.0191	CcSEcCtD
Oxcarbazepine—Hemiplegia—Temozolomide—malignant glioma	0.0115	0.0184	CcSEcCtD
Oxcarbazepine—Personality disorder—Carmustine—malignant glioma	0.00984	0.0157	CcSEcCtD
Oxcarbazepine—Altered state of consciousness—Temozolomide—malignant glioma	0.00891	0.0142	CcSEcCtD
Oxcarbazepine—Disorder sight—Temozolomide—malignant glioma	0.00864	0.0138	CcSEcCtD
Oxcarbazepine—Cerebral haemorrhage—Carmustine—malignant glioma	0.00769	0.0123	CcSEcCtD
Oxcarbazepine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00743	0.0119	CcSEcCtD
Oxcarbazepine—Transaminases increased—Carmustine—malignant glioma	0.007	0.0112	CcSEcCtD
Oxcarbazepine—Cerebration impaired—Temozolomide—malignant glioma	0.007	0.0112	CcSEcCtD
Oxcarbazepine—Haemorrhoids—Temozolomide—malignant glioma	0.007	0.0112	CcSEcCtD
Oxcarbazepine—Encephalopathy—Carmustine—malignant glioma	0.00663	0.0106	CcSEcCtD
Oxcarbazepine—Aphasia—Carmustine—malignant glioma	0.00656	0.0105	CcSEcCtD
Oxcarbazepine—Aphasia—Temozolomide—malignant glioma	0.00634	0.0101	CcSEcCtD
Oxcarbazepine—Hypokinesia—Carmustine—malignant glioma	0.00631	0.0101	CcSEcCtD
Oxcarbazepine—Interstitial lung disease—Carmustine—malignant glioma	0.00602	0.00961	CcSEcCtD
Oxcarbazepine—Interstitial lung disease—Temozolomide—malignant glioma	0.00581	0.00929	CcSEcCtD
Oxcarbazepine—Apathy—Temozolomide—malignant glioma	0.00576	0.00921	CcSEcCtD
Oxcarbazepine—Flat affect—Temozolomide—malignant glioma	0.00571	0.00912	CcSEcCtD
Oxcarbazepine—Stupor—Carmustine—malignant glioma	0.0057	0.00911	CcSEcCtD
Oxcarbazepine—Scotoma—Carmustine—malignant glioma	0.00561	0.00896	CcSEcCtD
Oxcarbazepine—Menorrhagia—Temozolomide—malignant glioma	0.00556	0.00888	CcSEcCtD
Oxcarbazepine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00546	0.00873	CcSEcCtD
Oxcarbazepine—Scotoma—Temozolomide—malignant glioma	0.00542	0.00866	CcSEcCtD
Oxcarbazepine—Rigors—Temozolomide—malignant glioma	0.00504	0.00805	CcSEcCtD
Oxcarbazepine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.005	0.00799	CcSEcCtD
Oxcarbazepine—Speech disorder—Carmustine—malignant glioma	0.00495	0.00791	CcSEcCtD
Oxcarbazepine—Speech disorder—Temozolomide—malignant glioma	0.00478	0.00764	CcSEcCtD
Oxcarbazepine—Disturbance in attention—Temozolomide—malignant glioma	0.00475	0.00759	CcSEcCtD
Oxcarbazepine—Thinking abnormal—Carmustine—malignant glioma	0.00465	0.00743	CcSEcCtD
Oxcarbazepine—Viral infection—Temozolomide—malignant glioma	0.00456	0.00728	CcSEcCtD
Oxcarbazepine—Gait disturbance—Carmustine—malignant glioma	0.00436	0.00697	CcSEcCtD
Oxcarbazepine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00435	0.00695	CcSEcCtD
Oxcarbazepine—Coordination abnormal—Carmustine—malignant glioma	0.00434	0.00693	CcSEcCtD
Oxcarbazepine—Gait disturbance—Temozolomide—malignant glioma	0.00422	0.00674	CcSEcCtD
Oxcarbazepine—Coordination abnormal—Temozolomide—malignant glioma	0.00419	0.0067	CcSEcCtD
Oxcarbazepine—Vaginal inflammation—Temozolomide—malignant glioma	0.00411	0.00658	CcSEcCtD
Oxcarbazepine—Depressed level of consciousness—Carmustine—malignant glioma	0.00411	0.00657	CcSEcCtD
Oxcarbazepine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00397	0.00635	CcSEcCtD
Oxcarbazepine—Vaginal infection—Temozolomide—malignant glioma	0.00388	0.00621	CcSEcCtD
Oxcarbazepine—Aplastic anaemia—Temozolomide—malignant glioma	0.00386	0.00617	CcSEcCtD
Oxcarbazepine—Abnormal vision—Carmustine—malignant glioma	0.00371	0.00593	CcSEcCtD
Oxcarbazepine—Mental disability—Carmustine—malignant glioma	0.00369	0.0059	CcSEcCtD
Oxcarbazepine—Abnormal vision—Temozolomide—malignant glioma	0.00359	0.00573	CcSEcCtD
Oxcarbazepine—Mental disability—Temozolomide—malignant glioma	0.00357	0.00571	CcSEcCtD
Oxcarbazepine—Ear pain—Temozolomide—malignant glioma	0.0035	0.00559	CcSEcCtD
Oxcarbazepine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00343	0.00549	CcSEcCtD
Oxcarbazepine—Vascular purpura—Temozolomide—malignant glioma	0.00334	0.00534	CcSEcCtD
Oxcarbazepine—Amnesia—Carmustine—malignant glioma	0.00329	0.00526	CcSEcCtD
Oxcarbazepine—Hot flush—Temozolomide—malignant glioma	0.00319	0.0051	CcSEcCtD
Oxcarbazepine—Amnesia—Temozolomide—malignant glioma	0.00318	0.00508	CcSEcCtD
Oxcarbazepine—Menopausal symptoms—Temozolomide—malignant glioma	0.00317	0.00506	CcSEcCtD
Oxcarbazepine—Thirst—Temozolomide—malignant glioma	0.00314	0.00502	CcSEcCtD
Oxcarbazepine—Hyponatraemia—Carmustine—malignant glioma	0.0031	0.00496	CcSEcCtD
Oxcarbazepine—Purpura—Temozolomide—malignant glioma	0.0031	0.00495	CcSEcCtD
Oxcarbazepine—Diplopia—Carmustine—malignant glioma	0.00309	0.00494	CcSEcCtD
Oxcarbazepine—Diplopia—Temozolomide—malignant glioma	0.00299	0.00477	CcSEcCtD
Oxcarbazepine—Affect lability—Temozolomide—malignant glioma	0.00294	0.0047	CcSEcCtD
Oxcarbazepine—Ataxia—Carmustine—malignant glioma	0.00291	0.00464	CcSEcCtD
Oxcarbazepine—Liver function test abnormal—Carmustine—malignant glioma	0.00285	0.00456	CcSEcCtD
Oxcarbazepine—Mood swings—Temozolomide—malignant glioma	0.00283	0.00452	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Carmustine—malignant glioma	0.00281	0.00449	CcSEcCtD
Oxcarbazepine—Ataxia—Temozolomide—malignant glioma	0.00281	0.00449	CcSEcCtD
Oxcarbazepine—Muscular weakness—Carmustine—malignant glioma	0.00273	0.00436	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Temozolomide—malignant glioma	0.00272	0.00434	CcSEcCtD
Oxcarbazepine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00269	0.0043	CcSEcCtD
Oxcarbazepine—Dysphagia—Carmustine—malignant glioma	0.00267	0.00427	CcSEcCtD
Oxcarbazepine—Muscular weakness—Temozolomide—malignant glioma	0.00263	0.00421	CcSEcCtD
Oxcarbazepine—Dysphagia—Temozolomide—malignant glioma	0.00258	0.00413	CcSEcCtD
Oxcarbazepine—Pancytopenia—Carmustine—malignant glioma	0.00254	0.00405	CcSEcCtD
Oxcarbazepine—Sweating increased—Temozolomide—malignant glioma	0.00251	0.00402	CcSEcCtD
Oxcarbazepine—Neutropenia—Carmustine—malignant glioma	0.0025	0.00399	CcSEcCtD
Oxcarbazepine—Bronchitis—Temozolomide—malignant glioma	0.00248	0.00397	CcSEcCtD
Oxcarbazepine—Pancytopenia—Temozolomide—malignant glioma	0.00245	0.00392	CcSEcCtD
Oxcarbazepine—Dysuria—Temozolomide—malignant glioma	0.00241	0.00386	CcSEcCtD
Oxcarbazepine—Neutropenia—Temozolomide—malignant glioma	0.00241	0.00386	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Carmustine—malignant glioma	0.00241	0.00385	CcSEcCtD
Oxcarbazepine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0024	0.00383	CcSEcCtD
Oxcarbazepine—Pneumonia—Carmustine—malignant glioma	0.0024	0.00383	CcSEcCtD
Oxcarbazepine—Pollakiuria—Temozolomide—malignant glioma	0.00238	0.00381	CcSEcCtD
Oxcarbazepine—Photosensitivity reaction—Temozolomide—malignant glioma	0.00236	0.00377	CcSEcCtD
Oxcarbazepine—Weight increased—Temozolomide—malignant glioma	0.00235	0.00375	CcSEcCtD
Oxcarbazepine—Renal failure—Carmustine—malignant glioma	0.00234	0.00374	CcSEcCtD
Oxcarbazepine—Weight decreased—Temozolomide—malignant glioma	0.00234	0.00373	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Temozolomide—malignant glioma	0.00233	0.00372	CcSEcCtD
Oxcarbazepine—Stomatitis—Carmustine—malignant glioma	0.00232	0.00371	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Carmustine—malignant glioma	0.00231	0.0037	CcSEcCtD
Oxcarbazepine—Pneumonia—Temozolomide—malignant glioma	0.00231	0.0037	CcSEcCtD
Oxcarbazepine—Infestation NOS—Temozolomide—malignant glioma	0.0023	0.00368	CcSEcCtD
Oxcarbazepine—Infestation—Temozolomide—malignant glioma	0.0023	0.00368	CcSEcCtD
Oxcarbazepine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00228	0.00365	CcSEcCtD
Oxcarbazepine—Stomatitis—Temozolomide—malignant glioma	0.00224	0.00359	CcSEcCtD
Oxcarbazepine—Urinary tract infection—Temozolomide—malignant glioma	0.00224	0.00358	CcSEcCtD
Oxcarbazepine—Hepatobiliary disease—Temozolomide—malignant glioma	0.00218	0.00348	CcSEcCtD
Oxcarbazepine—Sinusitis—Temozolomide—malignant glioma	0.00216	0.00345	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Carmustine—malignant glioma	0.00213	0.0034	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Carmustine—malignant glioma	0.00211	0.00337	CcSEcCtD
Oxcarbazepine—Hepatitis—Temozolomide—malignant glioma	0.00207	0.0033	CcSEcCtD
Oxcarbazepine—Visual impairment—Carmustine—malignant glioma	0.00206	0.00329	CcSEcCtD
Oxcarbazepine—Hypoaesthesia—Temozolomide—malignant glioma	0.00206	0.00329	CcSEcCtD
Oxcarbazepine—Pharyngitis—Temozolomide—malignant glioma	0.00205	0.00328	CcSEcCtD
Oxcarbazepine—Oedema peripheral—Temozolomide—malignant glioma	0.00204	0.00325	CcSEcCtD
Oxcarbazepine—Amitriptyline—NTRK2—malignant glioma	0.00201	0.0653	CrCbGaD
Oxcarbazepine—Eye disorder—Carmustine—malignant glioma	0.002	0.00319	CcSEcCtD
Oxcarbazepine—Visual impairment—Temozolomide—malignant glioma	0.00199	0.00318	CcSEcCtD
Oxcarbazepine—Flushing—Carmustine—malignant glioma	0.00198	0.00317	CcSEcCtD
Oxcarbazepine—Erythema multiforme—Temozolomide—malignant glioma	0.00195	0.00312	CcSEcCtD
Oxcarbazepine—Eye disorder—Temozolomide—malignant glioma	0.00193	0.00309	CcSEcCtD
Oxcarbazepine—Tinnitus—Temozolomide—malignant glioma	0.00193	0.00308	CcSEcCtD
Oxcarbazepine—Cardiac disorder—Temozolomide—malignant glioma	0.00192	0.00306	CcSEcCtD
Oxcarbazepine—Flushing—Temozolomide—malignant glioma	0.00192	0.00306	CcSEcCtD
Oxcarbazepine—Arrhythmia—Carmustine—malignant glioma	0.00191	0.00305	CcSEcCtD
Oxcarbazepine—Alopecia—Carmustine—malignant glioma	0.00189	0.00302	CcSEcCtD
Oxcarbazepine—Angiopathy—Temozolomide—malignant glioma	0.00187	0.003	CcSEcCtD
Oxcarbazepine—Mental disorder—Carmustine—malignant glioma	0.00187	0.00299	CcSEcCtD
Oxcarbazepine—Immune system disorder—Temozolomide—malignant glioma	0.00187	0.00298	CcSEcCtD
Oxcarbazepine—Malnutrition—Carmustine—malignant glioma	0.00186	0.00297	CcSEcCtD
Oxcarbazepine—Chills—Temozolomide—malignant glioma	0.00185	0.00296	CcSEcCtD
Oxcarbazepine—Alopecia—Temozolomide—malignant glioma	0.00183	0.00292	CcSEcCtD
Oxcarbazepine—Mental disorder—Temozolomide—malignant glioma	0.00181	0.00289	CcSEcCtD
Oxcarbazepine—Back pain—Carmustine—malignant glioma	0.0018	0.00288	CcSEcCtD
Oxcarbazepine—Malnutrition—Temozolomide—malignant glioma	0.0018	0.00287	CcSEcCtD
Oxcarbazepine—Dysgeusia—Temozolomide—malignant glioma	0.00176	0.00281	CcSEcCtD
Oxcarbazepine—Vision blurred—Carmustine—malignant glioma	0.00175	0.0028	CcSEcCtD
Oxcarbazepine—Tremor—Carmustine—malignant glioma	0.00174	0.00279	CcSEcCtD
Oxcarbazepine—Back pain—Temozolomide—malignant glioma	0.00174	0.00278	CcSEcCtD
Oxcarbazepine—Warfarin—CYP2C18—malignant glioma	0.00172	0.0558	CrCbGaD
Oxcarbazepine—Agitation—Carmustine—malignant glioma	0.00171	0.00273	CcSEcCtD
Oxcarbazepine—Vision blurred—Temozolomide—malignant glioma	0.0017	0.00271	CcSEcCtD
Oxcarbazepine—Tremor—Temozolomide—malignant glioma	0.00169	0.00269	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Temozolomide—malignant glioma	0.00167	0.00267	CcSEcCtD
Oxcarbazepine—Leukopenia—Carmustine—malignant glioma	0.00167	0.00266	CcSEcCtD
Oxcarbazepine—Agitation—Temozolomide—malignant glioma	0.00165	0.00264	CcSEcCtD
Oxcarbazepine—Angioedema—Temozolomide—malignant glioma	0.00164	0.00263	CcSEcCtD
Oxcarbazepine—Malaise—Temozolomide—malignant glioma	0.00162	0.00259	CcSEcCtD
Oxcarbazepine—Vertigo—Temozolomide—malignant glioma	0.00162	0.00258	CcSEcCtD
Oxcarbazepine—Convulsion—Carmustine—malignant glioma	0.00161	0.00258	CcSEcCtD
Oxcarbazepine—Leukopenia—Temozolomide—malignant glioma	0.00161	0.00257	CcSEcCtD
Oxcarbazepine—Hypertension—Carmustine—malignant glioma	0.00161	0.00257	CcSEcCtD
Oxcarbazepine—Nepafenac—PTGS1—malignant glioma	0.0016	0.0519	CrCbGaD
Oxcarbazepine—Palpitations—Temozolomide—malignant glioma	0.00159	0.00254	CcSEcCtD
Oxcarbazepine—Chest pain—Carmustine—malignant glioma	0.00158	0.00253	CcSEcCtD
Oxcarbazepine—Myalgia—Carmustine—malignant glioma	0.00158	0.00253	CcSEcCtD
Oxcarbazepine—Anxiety—Carmustine—malignant glioma	0.00158	0.00252	CcSEcCtD
Oxcarbazepine—Cough—Temozolomide—malignant glioma	0.00157	0.00251	CcSEcCtD
Oxcarbazepine—Magnesium salicylate—PTGS1—malignant glioma	0.00156	0.0507	CrCbGaD
Oxcarbazepine—Convulsion—Temozolomide—malignant glioma	0.00156	0.00249	CcSEcCtD
Oxcarbazepine—Hypertension—Temozolomide—malignant glioma	0.00155	0.00248	CcSEcCtD
Oxcarbazepine—Confusional state—Carmustine—malignant glioma	0.00153	0.00245	CcSEcCtD
Oxcarbazepine—Myalgia—Temozolomide—malignant glioma	0.00153	0.00245	CcSEcCtD
Oxcarbazepine—Arthralgia—Temozolomide—malignant glioma	0.00153	0.00245	CcSEcCtD
Oxcarbazepine—Anxiety—Temozolomide—malignant glioma	0.00153	0.00244	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00152	0.00243	CcSEcCtD
Oxcarbazepine—Epinastine—CYP2B6—malignant glioma	0.00152	0.0493	CrCbGaD
Oxcarbazepine—Discomfort—Temozolomide—malignant glioma	0.00151	0.00242	CcSEcCtD
Oxcarbazepine—Infection—Carmustine—malignant glioma	0.00151	0.00241	CcSEcCtD
Oxcarbazepine—Piroxicam—PTGS1—malignant glioma	0.0015	0.0486	CrCbGaD
Oxcarbazepine—Dry mouth—Temozolomide—malignant glioma	0.0015	0.00239	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Carmustine—malignant glioma	0.00149	0.00238	CcSEcCtD
Oxcarbazepine—Tachycardia—Carmustine—malignant glioma	0.00148	0.00237	CcSEcCtD
Oxcarbazepine—Confusional state—Temozolomide—malignant glioma	0.00148	0.00237	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Temozolomide—malignant glioma	0.00147	0.00235	CcSEcCtD
Oxcarbazepine—Infection—Temozolomide—malignant glioma	0.00146	0.00233	CcSEcCtD
Oxcarbazepine—Anorexia—Carmustine—malignant glioma	0.00145	0.00231	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Temozolomide—malignant glioma	0.00144	0.0023	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Temozolomide—malignant glioma	0.00144	0.0023	CcSEcCtD
Oxcarbazepine—Skin disorder—Temozolomide—malignant glioma	0.00143	0.00228	CcSEcCtD
Oxcarbazepine—Hypotension—Carmustine—malignant glioma	0.00142	0.00227	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Temozolomide—malignant glioma	0.00142	0.00227	CcSEcCtD
Oxcarbazepine—Anorexia—Temozolomide—malignant glioma	0.0014	0.00224	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00138	0.00221	CcSEcCtD
Oxcarbazepine—Insomnia—Carmustine—malignant glioma	0.00137	0.0022	CcSEcCtD
Oxcarbazepine—Clobazam—CYP2C18—malignant glioma	0.00137	0.0445	CrCbGaD
Oxcarbazepine—Dyspnoea—Carmustine—malignant glioma	0.00135	0.00216	CcSEcCtD
Oxcarbazepine—Somnolence—Carmustine—malignant glioma	0.00135	0.00216	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00134	0.00214	CcSEcCtD
Oxcarbazepine—Salsalate—PTGS1—malignant glioma	0.00133	0.0431	CrCbGaD
Oxcarbazepine—Insomnia—Temozolomide—malignant glioma	0.00133	0.00212	CcSEcCtD
Oxcarbazepine—Decreased appetite—Carmustine—malignant glioma	0.00132	0.00211	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00131	0.0021	CcSEcCtD
Oxcarbazepine—Dyspnoea—Temozolomide—malignant glioma	0.00131	0.00209	CcSEcCtD
Oxcarbazepine—Somnolence—Temozolomide—malignant glioma	0.0013	0.00209	CcSEcCtD
Oxcarbazepine—Pain—Carmustine—malignant glioma	0.0013	0.00208	CcSEcCtD
Oxcarbazepine—Constipation—Carmustine—malignant glioma	0.0013	0.00208	CcSEcCtD
Oxcarbazepine—Dyspepsia—Temozolomide—malignant glioma	0.00129	0.00207	CcSEcCtD
Oxcarbazepine—Decreased appetite—Temozolomide—malignant glioma	0.00128	0.00204	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00127	0.00203	CcSEcCtD
Oxcarbazepine—Fatigue—Temozolomide—malignant glioma	0.00127	0.00202	CcSEcCtD
Oxcarbazepine—Constipation—Temozolomide—malignant glioma	0.00126	0.00201	CcSEcCtD
Oxcarbazepine—Pain—Temozolomide—malignant glioma	0.00126	0.00201	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Carmustine—malignant glioma	0.00125	0.002	CcSEcCtD
Oxcarbazepine—Amitriptyline—NTRK1—malignant glioma	0.00124	0.0404	CrCbGaD
Oxcarbazepine—Gastrointestinal pain—Carmustine—malignant glioma	0.00124	0.00199	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Temozolomide—malignant glioma	0.00121	0.00193	CcSEcCtD
Oxcarbazepine—Body temperature increased—Carmustine—malignant glioma	0.0012	0.00192	CcSEcCtD
Oxcarbazepine—Abdominal pain—Carmustine—malignant glioma	0.0012	0.00192	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Temozolomide—malignant glioma	0.0012	0.00192	CcSEcCtD
Oxcarbazepine—Urticaria—Temozolomide—malignant glioma	0.00117	0.00186	CcSEcCtD
Oxcarbazepine—Abdominal pain—Temozolomide—malignant glioma	0.00116	0.00185	CcSEcCtD
Oxcarbazepine—Body temperature increased—Temozolomide—malignant glioma	0.00116	0.00185	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Carmustine—malignant glioma	0.00112	0.00179	CcSEcCtD
Oxcarbazepine—Asthenia—Carmustine—malignant glioma	0.00109	0.00174	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Temozolomide—malignant glioma	0.00108	0.00173	CcSEcCtD
Oxcarbazepine—Asthenia—Temozolomide—malignant glioma	0.00105	0.00168	CcSEcCtD
Oxcarbazepine—Modafinil—CYP2B6—malignant glioma	0.00105	0.0339	CrCbGaD
Oxcarbazepine—Diarrhoea—Carmustine—malignant glioma	0.00104	0.00166	CcSEcCtD
Oxcarbazepine—Pruritus—Temozolomide—malignant glioma	0.00104	0.00166	CcSEcCtD
Oxcarbazepine—Clobazam—CYP2B6—malignant glioma	0.00102	0.033	CrCbGaD
Oxcarbazepine—Dizziness—Carmustine—malignant glioma	0.001	0.00161	CcSEcCtD
Oxcarbazepine—Diarrhoea—Temozolomide—malignant glioma	0.001	0.00161	CcSEcCtD
Oxcarbazepine—Dizziness—Temozolomide—malignant glioma	0.000971	0.00155	CcSEcCtD
Oxcarbazepine—Vomiting—Carmustine—malignant glioma	0.000966	0.00154	CcSEcCtD
Oxcarbazepine—Rash—Carmustine—malignant glioma	0.000958	0.00153	CcSEcCtD
Oxcarbazepine—Dermatitis—Carmustine—malignant glioma	0.000957	0.00153	CcSEcCtD
Oxcarbazepine—Carbamazepine—CYP2B6—malignant glioma	0.000954	0.0309	CrCbGaD
Oxcarbazepine—Headache—Carmustine—malignant glioma	0.000952	0.00152	CcSEcCtD
Oxcarbazepine—Vomiting—Temozolomide—malignant glioma	0.000933	0.00149	CcSEcCtD
Oxcarbazepine—Rash—Temozolomide—malignant glioma	0.000926	0.00148	CcSEcCtD
Oxcarbazepine—Dermatitis—Temozolomide—malignant glioma	0.000925	0.00148	CcSEcCtD
Oxcarbazepine—Headache—Temozolomide—malignant glioma	0.00092	0.00147	CcSEcCtD
Oxcarbazepine—Nepafenac—PTGS2—malignant glioma	0.000914	0.0296	CrCbGaD
Oxcarbazepine—Nausea—Carmustine—malignant glioma	0.000902	0.00144	CcSEcCtD
Oxcarbazepine—Magnesium salicylate—PTGS2—malignant glioma	0.000893	0.029	CrCbGaD
Oxcarbazepine—Modafinil—SLC6A3—malignant glioma	0.000891	0.0289	CrCbGaD
Oxcarbazepine—Mianserin—CYP2B6—malignant glioma	0.000879	0.0285	CrCbGaD
Oxcarbazepine—Nausea—Temozolomide—malignant glioma	0.000872	0.00139	CcSEcCtD
Oxcarbazepine—Desipramine—CYP2C18—malignant glioma	0.000871	0.0283	CrCbGaD
Oxcarbazepine—Piroxicam—PTGS2—malignant glioma	0.000856	0.0278	CrCbGaD
Oxcarbazepine—Diazepam—CYP2C18—malignant glioma	0.0008	0.026	CrCbGaD
Oxcarbazepine—Salsalate—PTGS2—malignant glioma	0.000759	0.0246	CrCbGaD
Oxcarbazepine—Mianserin—SLC6A3—malignant glioma	0.000749	0.0243	CrCbGaD
Oxcarbazepine—Imipramine—CYP2C18—malignant glioma	0.000739	0.024	CrCbGaD
Oxcarbazepine—Promethazine—CYP2B6—malignant glioma	0.000712	0.0231	CrCbGaD
Oxcarbazepine—Desipramine—CYP2B6—malignant glioma	0.000647	0.021	CrCbGaD
Oxcarbazepine—Trimipramine—SLC6A3—malignant glioma	0.00063	0.0204	CrCbGaD
Oxcarbazepine—Diazepam—CYP2B6—malignant glioma	0.000594	0.0193	CrCbGaD
Oxcarbazepine—Desipramine—SLC6A3—malignant glioma	0.000551	0.0179	CrCbGaD
Oxcarbazepine—Imipramine—CYP2B6—malignant glioma	0.000548	0.0178	CrCbGaD
Oxcarbazepine—Amitriptyline—CYP2B6—malignant glioma	0.000545	0.0177	CrCbGaD
Oxcarbazepine—Nortriptyline—PTGS1—malignant glioma	0.000517	0.0168	CrCbGaD
Oxcarbazepine—Imipramine—SLC6A3—malignant glioma	0.000467	0.0152	CrCbGaD
Oxcarbazepine—Diazepam—PTGS1—malignant glioma	0.000391	0.0127	CrCbGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000292	0.00227	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000291	0.00226	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—FN1—malignant glioma	0.000279	0.00217	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000276	0.00214	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000275	0.00213	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL1B—malignant glioma	0.00027	0.0021	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—FGFR1—malignant glioma	0.000266	0.00207	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000266	0.00207	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000265	0.00206	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—EGF—malignant glioma	0.000264	0.00205	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000263	0.00204	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—F2—malignant glioma	0.000259	0.00201	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000257	0.002	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000251	0.00195	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—KDR—malignant glioma	0.000251	0.00195	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000249	0.00193	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000248	0.00193	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IFNG—malignant glioma	0.000247	0.00192	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000246	0.00191	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MET—malignant glioma	0.000246	0.00191	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.000243	0.00189	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ATP1B2—malignant glioma	0.000243	0.00189	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000241	0.00187	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000236	0.00183	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000232	0.00181	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PTK2—malignant glioma	0.000227	0.00177	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—PTPN11—malignant glioma	0.000227	0.00177	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—HES1—malignant glioma	0.000223	0.00174	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—NCOR1—malignant glioma	0.000222	0.00173	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL1B—malignant glioma	0.00022	0.00171	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL2—malignant glioma	0.000219	0.0017	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RTEL1—malignant glioma	0.000214	0.00167	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000213	0.00165	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00021	0.00163	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MMP2—malignant glioma	0.000205	0.00159	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—APOD—malignant glioma	0.000205	0.00159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000204	0.00159	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000201	0.00157	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—TNF—malignant glioma	0.000196	0.00152	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IFNG—malignant glioma	0.000196	0.00152	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RTEL1—malignant glioma	0.000193	0.0015	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000191	0.00149	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTP1—malignant glioma	0.00019	0.00148	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—FGFR1—malignant glioma	0.00019	0.00148	CbGpPWpGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000189	0.00147	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000188	0.00146	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	0.000188	0.00146	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—RAF1—malignant glioma	0.000181	0.00141	CbGpPWpGaD
Oxcarbazepine—ALB—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00018	0.0014	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—ERBB2—malignant glioma	0.00018	0.00139	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KDR—malignant glioma	0.000179	0.00139	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—ANGPT2—malignant glioma	0.000179	0.00139	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000178	0.00138	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000177	0.00137	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MET—malignant glioma	0.000175	0.00136	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL1B—malignant glioma	0.000175	0.00136	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—NOTCH1—malignant glioma	0.000169	0.00131	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000165	0.00128	CbGpPWpGaD
Oxcarbazepine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000164	0.00128	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000163	0.00127	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PTPN11—malignant glioma	0.000162	0.00126	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—VEGFA—malignant glioma	0.00016	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—malignant glioma	0.00016	0.00124	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—PPARG—malignant glioma	0.000159	0.00124	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HIST1H3B—malignant glioma	0.000155	0.0012	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000155	0.0012	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MMP9—malignant glioma	0.000154	0.0012	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MYB—malignant glioma	0.000154	0.00119	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000153	0.00119	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000152	0.00118	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—AKT2—malignant glioma	0.000151	0.00117	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000148	0.00115	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP2—malignant glioma	0.000146	0.00114	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—COX8A—malignant glioma	0.000143	0.00111	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—malignant glioma	0.000141	0.00109	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—FGF2—malignant glioma	0.000139	0.00108	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—VEGFA—malignant glioma	0.000138	0.00107	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000138	0.00107	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000137	0.00107	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000133	0.00103	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—RAF1—malignant glioma	0.000129	0.00101	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—ERBB2—malignant glioma	0.000128	0.000995	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—malignant glioma	0.000127	0.000985	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—EGFR—malignant glioma	0.000124	0.000967	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000124	0.000962	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000124	0.000962	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—COX8A—malignant glioma	0.000123	0.000957	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ASMT—malignant glioma	0.000122	0.000945	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—H3F3A—malignant glioma	0.00012	0.000931	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000118	0.00092	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—KRAS—malignant glioma	0.000118	0.000913	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000117	0.00091	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000116	0.0009	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000114	0.00089	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—BCAN—malignant glioma	0.000114	0.000888	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000113	0.000877	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—COX8A—malignant glioma	0.000111	0.000859	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00011	0.000856	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP9—malignant glioma	0.00011	0.000854	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000108	0.000842	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ASMT—malignant glioma	0.000105	0.000814	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000105	0.000814	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000104	0.000809	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000102	0.000795	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	9.88e-05	0.000768	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KNG1—malignant glioma	9.87e-05	0.000767	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—malignant glioma	9.87e-05	0.000767	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—BCAN—malignant glioma	9.85e-05	0.000765	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—STAT3—malignant glioma	9.77e-05	0.000759	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IFNA2—malignant glioma	9.67e-05	0.000751	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC5A5—malignant glioma	9.61e-05	0.000747	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ASMT—malignant glioma	9.4e-05	0.000731	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RAF1—malignant glioma	9.29e-05	0.000722	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—IDH2—malignant glioma	9.22e-05	0.000716	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	9.19e-05	0.000714	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SOD1—malignant glioma	9.17e-05	0.000712	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	9.15e-05	0.000711	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	9.07e-05	0.000705	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EGFR—malignant glioma	8.88e-05	0.00069	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—BCAN—malignant glioma	8.84e-05	0.000687	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2B6—malignant glioma	8.66e-05	0.000673	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—malignant glioma	8.46e-05	0.000657	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PTK2—malignant glioma	8.42e-05	0.000654	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—KRAS—malignant glioma	8.39e-05	0.000652	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	8.33e-05	0.000648	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—IDH2—malignant glioma	7.94e-05	0.000617	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—IDH1—malignant glioma	7.92e-05	0.000616	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SPHK1—malignant glioma	7.67e-05	0.000596	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP2C18—malignant glioma	7.51e-05	0.000584	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.48e-05	0.000582	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2B6—malignant glioma	7.46e-05	0.00058	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—IDH2—malignant glioma	7.12e-05	0.000554	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	7.08e-05	0.00055	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PDGFB—malignant glioma	7.07e-05	0.00055	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—IDH1—malignant glioma	6.83e-05	0.00053	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	6.72e-05	0.000522	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—CAV1—malignant glioma	6.7e-05	0.000521	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2B6—malignant glioma	6.7e-05	0.000521	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—COX8A—malignant glioma	6.65e-05	0.000517	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SPHK1—malignant glioma	6.6e-05	0.000513	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP2C18—malignant glioma	6.47e-05	0.000503	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—F2—malignant glioma	6.38e-05	0.000496	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—FN1—malignant glioma	6.38e-05	0.000496	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—AKT1—malignant glioma	6.3e-05	0.000489	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—IDH1—malignant glioma	6.13e-05	0.000476	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CG—malignant glioma	6.1e-05	0.000474	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.1e-05	0.000474	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—malignant glioma	6.08e-05	0.000472	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—EGF—malignant glioma	6.03e-05	0.000469	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PTPN11—malignant glioma	6e-05	0.000466	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SPHK1—malignant glioma	5.93e-05	0.000461	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP2C18—malignant glioma	5.81e-05	0.000451	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS1—malignant glioma	5.69e-05	0.000442	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ASMT—malignant glioma	5.65e-05	0.000439	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT2—malignant glioma	5.59e-05	0.000434	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.56e-05	0.000432	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	5.53e-05	0.00043	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	5.48e-05	0.000426	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CD—malignant glioma	5.37e-05	0.000417	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.36e-05	0.000417	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—BCAN—malignant glioma	5.32e-05	0.000413	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—BCHE—malignant glioma	5.29e-05	0.000411	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—malignant glioma	5.23e-05	0.000407	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—SLC5A5—malignant glioma	5.23e-05	0.000406	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.99e-05	0.000388	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS1—malignant glioma	4.9e-05	0.000381	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.89e-05	0.00038	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.81e-05	0.000374	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RAF1—malignant glioma	4.79e-05	0.000372	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—malignant glioma	4.7e-05	0.000365	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CB—malignant glioma	4.68e-05	0.000363	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—BCHE—malignant glioma	4.56e-05	0.000354	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.52e-05	0.000351	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—SLC5A5—malignant glioma	4.5e-05	0.00035	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS1—malignant glioma	4.4e-05	0.000342	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	4.39e-05	0.000341	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—IL2—malignant glioma	4.3e-05	0.000334	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—IDH2—malignant glioma	4.28e-05	0.000333	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.26e-05	0.000331	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.22e-05	0.000328	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—malignant glioma	4.21e-05	0.000327	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	4.15e-05	0.000322	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CAT—malignant glioma	4.1e-05	0.000318	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—BCHE—malignant glioma	4.09e-05	0.000318	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—SLC5A5—malignant glioma	4.04e-05	0.000314	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2B6—malignant glioma	4.03e-05	0.000313	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NCOR1—malignant glioma	3.87e-05	0.000301	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.82e-05	0.000297	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.79e-05	0.000294	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—IDH1—malignant glioma	3.68e-05	0.000286	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.68e-05	0.000286	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—malignant glioma	3.65e-05	0.000284	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—malignant glioma	3.63e-05	0.000282	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SPHK1—malignant glioma	3.57e-05	0.000277	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CAT—malignant glioma	3.53e-05	0.000274	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.49e-05	0.000271	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NCOR1—malignant glioma	3.33e-05	0.000259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.3e-05	0.000257	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—malignant glioma	3.26e-05	0.000253	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CAT—malignant glioma	3.17e-05	0.000246	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CAV1—malignant glioma	3.15e-05	0.000245	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—KRAS—malignant glioma	3.1e-05	0.000241	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NCOR1—malignant glioma	2.99e-05	0.000233	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.87e-05	0.000223	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PIK3CA—malignant glioma	2.85e-05	0.000222	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.82e-05	0.00022	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PPARG—malignant glioma	2.77e-05	0.000216	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—malignant glioma	2.76e-05	0.000214	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CAV1—malignant glioma	2.72e-05	0.000211	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS1—malignant glioma	2.65e-05	0.000206	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.6e-05	0.000202	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.53e-05	0.000196	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CG—malignant glioma	2.47e-05	0.000192	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—BCHE—malignant glioma	2.46e-05	0.000191	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CAV1—malignant glioma	2.44e-05	0.00019	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.43e-05	0.000189	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PPARG—malignant glioma	2.39e-05	0.000186	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.33e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—AKT1—malignant glioma	2.33e-05	0.000181	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.22e-05	0.000173	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.2e-05	0.000171	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTGS2—malignant glioma	2.18e-05	0.00017	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CD—malignant glioma	2.18e-05	0.000169	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PPARG—malignant glioma	2.14e-05	0.000167	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.96e-05	0.000152	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.95e-05	0.000152	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CAT—malignant glioma	1.91e-05	0.000148	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PTEN—malignant glioma	1.9e-05	0.000148	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CB—malignant glioma	1.9e-05	0.000147	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTGS2—malignant glioma	1.88e-05	0.000146	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.8e-05	0.00014	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.7e-05	0.000132	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTGS2—malignant glioma	1.69e-05	0.000131	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PTEN—malignant glioma	1.64e-05	0.000127	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PTEN—malignant glioma	1.47e-05	0.000114	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CAV1—malignant glioma	1.47e-05	0.000114	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.34e-05	0.000104	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.34e-05	0.000104	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PPARG—malignant glioma	1.29e-05	0.0001	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.17e-05	9.13e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—PIK3CA—malignant glioma	1.16e-05	8.98e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—AKT1—malignant glioma	1.1e-05	8.52e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.04e-05	8.06e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.02e-05	7.96e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTGS2—malignant glioma	1.01e-05	7.88e-05	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—AKT1—malignant glioma	9.44e-06	7.34e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PTEN—malignant glioma	8.85e-06	6.87e-05	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—AKT1—malignant glioma	8.48e-06	6.59e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—PIK3CA—malignant glioma	6.24e-06	4.85e-05	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—AKT1—malignant glioma	5.1e-06	3.96e-05	CbGpPWpGaD
